Simplicity Solutions’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$608K Buy
3,532
+604
+21% +$92.8K 0.02% 603
2023
Q3
$433K Buy
2,928
+860
+42% +$155K 0.01% 635
2023
Q2
$452K Sell
2,068
-80
-4% -$17.8K 0.01% 697
2023
Q1
$470K Buy
2,148
+693
+48% +$150K 0.01% 715
2022
Q4
$303K Sell
1,455
-83
-5% -$18.2K 0.04% 481
2022
Q3
$336K Buy
1,538
+409
+36% +$93.1K 0.05% 418
2022
Q2
$237K Buy
+1,129
New +$240K 0.03% 515
2021
Q1
Sell
-2,054
Closed -$437K 869
2020
Q4
$437K Buy
2,054
+823
+67% +$164K 0.01% 710
2020
Q3
$211K Buy
+1,231
New +$227K ﹤0.01% 815
2017
Q3
Sell
-3,167
Closed -$247K 341
2017
Q2
$247K Buy
3,167
+49
+2% +$3.51K 0.03% 359
2017
Q1
$224K Buy
+3,118
New +$215K 0.03% 361
2016
Q1
Sell
-21,884
Closed -$1.18M 444
2015
Q4
$1.18M Buy
+21,884
New +$1.23M 0.14% 203

Other funds holding RMD

Simplicity Solutions's RMD Position: Q4 2023 in Review

Simplicity Solutions increased its ResMed (RMD) stake by 21% in Q4 2023, buying an estimated $92.8K and bringing the position to 3,532 shares worth $608K. The position accounts for 0.02% of the portfolio, ranked #603.

Simplicity Solutions first reported a position in RMD in Q4 2015 and has held it in 12 quarters since. The position peaked at $1.18M in Q4 2015. 688 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • Simplicity Solutions held 3,532 shares of ResMed worth $608K as of Q4 2023.
  • Simplicity Solutions bought 604 ResMed shares in Q4 2023, an estimated $92.8K.
  • ResMed made up 0.02% of Simplicity Solutions's portfolio in Q4 2023, its #603 holding.
  • Simplicity Solutions first reported a position in ResMed in Q4 2015 and has held it in 12 quarters since.
  • Simplicity Solutions's ResMed position peaked at $1.18M in Q4 2015.
  • 688 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.